Journal of neurosurgery. Case lessons · 2025
Symptomatic cerebral hyperperfusion after occipital artery-posterior cerebral artery bypass in a patient with moyamoya disease: illustrative case.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kimata Jin, Tokairin Kikutaro, Uchino Haruto, Ito Masaki, Fujimura Miki
Аннотация
BACKGROUND: Moyamoya disease (MMD) is a progressive, steno-occlusive cerebrovascular disorder. Posterior cerebral artery (PCA) stenosis can develop after successful anterior circulation revascularization. Although symptomatic cerebral hyperperfusion (CHP) is a recognized complication of anterior revascularization, it is rarely reported following occipital artery (OA)-PCA bypass.
OBSERVATIONS: The authors report the case of a 50-year-old woman with MMD who developed symptomatic hemodynamic compromise due to progressive right PCA stenosis 10 years after bilateral superficial temporal artery-middle cerebral artery bypass and indirect revascularization. She underwent OA-PCA bypass with encephalo-myo-synangiosis. On postoperative day 1, single-photon emission CT revealed focal CHP in the right parietal lobe, with cerebral blood flow (CBF) increasing to 160% of preoperative levels. The patient developed a pulsatile headache and left-sided tongue numbness. By postoperative day 7, CBF had decreased to 110%, and perfusion had improved throughout the right parietal-occipital region. With strict blood pressure control and minocycline administration, both symptoms and CHP resolved. At the 1-year follow-up, the patient remained symptom free without stroke recurrence.
LESSONS: Symptomatic CHP can occur after OA-PCA bypass in MMD. Perioperative CHP management, including blood pressure control and anti-inflammatory therapy, is essential for optimal outcomes of posterior circulation bypass. https://thejns.org/doi/10.3171/CASE25486.
OBSERVATIONS: The authors report the case of a 50-year-old woman with MMD who developed symptomatic hemodynamic compromise due to progressive right PCA stenosis 10 years after bilateral superficial temporal artery-middle cerebral artery bypass and indirect revascularization. She underwent OA-PCA bypass with encephalo-myo-synangiosis. On postoperative day 1, single-photon emission CT revealed focal CHP in the right parietal lobe, with cerebral blood flow (CBF) increasing to 160% of preoperative levels. The patient developed a pulsatile headache and left-sided tongue numbness. By postoperative day 7, CBF had decreased to 110%, and perfusion had improved throughout the right parietal-occipital region. With strict blood pressure control and minocycline administration, both symptoms and CHP resolved. At the 1-year follow-up, the patient remained symptom free without stroke recurrence.
LESSONS: Symptomatic CHP can occur after OA-PCA bypass in MMD. Perioperative CHP management, including blood pressure control and anti-inflammatory therapy, is essential for optimal outcomes of posterior circulation bypass. https://thejns.org/doi/10.3171/CASE25486.